Patarroyo-Rodriguez L

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

5 papers · ORCID

ArticleKetamine

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.

Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL +2

Europe PMC2026
ArticlePsilocybin

Psilocybin and Bipolar Depression: Promise and Prudence.

Marques MG, Patarroyo-Rodriguez L, Singh B

Europe PMC2026
ArticleKetamine

Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.

Elmosalamy A, Tarikogullari I, Patarroyo-Rodriguez L +5

Europe PMC2025
ArticleKetamine

Ketamine Reduces Suicidality-Associated Emergency Department Utilization in Patients With Treatment-Resistant Depression: A 6-Month Mirror-Image Study.

Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL +3

Europe PMC2025
ArticleKetamine

Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression.

Patarroyo-Rodriguez L, Pazdernik V, Vande Voort JL +2

Europe PMC2024